Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
Md Entaz Bahar, Hyun Joon Kim, Deok Ryong Kim
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 186

Showing 1-25 of 186 citing articles:

Tumor biomarkers for diagnosis, prognosis and targeted therapy
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 110
Targeting MAPK-ERK/JNK pathway: A potential intervention mechanism of myocardial fibrosis in heart failure
Zeyu Zhang, Zhihua Yang, Shuai Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116413-116413
Open Access | Times Cited: 15
Multiple myeloma: signaling pathways and targeted therapy
Qizhong Lu, Donghui Yang, Hexian Li, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 13
Discovery of Small Molecules that Bind to Son of Sevenless 2 (SOS2)
Krzysztof M. Zak, Alex G. Waterson, Leonhard Geist, et al.
Journal of Medicinal Chemistry (2025)
Open Access | Times Cited: 1
High-dose ascorbic acid synergizes with anti-PD1 therapy in non-small cell lung cancer in vitro and in vivo models
Hak Su Kim, Seunghyun Kwon, Ok Kyung Choi, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Allosteric modulation of NF1 GAP: Differential distributions of catalytically competent populations in loss‐of‐function and gain‐of‐function mutants
Liang Xu, Hyunbum Jang, Ruth Nussinov
Protein Science (2025) Vol. 34, Iss. 2
Open Access | Times Cited: 1
Metformin-based nanomedicines for reprogramming tumor immune microenvironment
Jieyu Liu, Xiaoling Li, Yinggang Li, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 993-1016
Closed Access | Times Cited: 11
Oncogenic Pathways and Targeted Therapies in Ovarian Cancer
Carolina Lliberos, Gary Richardson, Antonella Papa
Biomolecules (2024) Vol. 14, Iss. 5, pp. 585-585
Open Access | Times Cited: 7
Nanomedicine-based disulfiram and metal ion co-delivery strategies for cancer treatment
Xinyue Shen, Huixiang Sheng, Ying Zhang, et al.
International Journal of Pharmaceutics X (2024) Vol. 7, pp. 100248-100248
Open Access | Times Cited: 6
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer
Mohd Rais Mustafa, Kashif Abbas, Mudassir Alam, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
Sílvia Casacuberta‐Serra, Íñigo González-Larreategui, Daniel Capitán-Leo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Phyto-therapeutics as anti-cancer agents in breast cancer: Pathway targeting and mechanistic elucidation
Abdullah Almilaibary
Saudi Journal of Biological Sciences (2024) Vol. 31, Iss. 3, pp. 103935-103935
Open Access | Times Cited: 5
Emerging biomarkers and molecular targets for precision medicine in cervical cancer
Pankaj Garg, Madhu Krishna, Ayalur Raghu Subbalakshmi, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 3, pp. 189106-189106
Closed Access | Times Cited: 5
Oxidative stress-mediated epigenetic remodeling, metastatic progression and cell signaling in cancer
Abdul Rehman Phull, Sadia Qamar Arain, Abdul Majid, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 4, pp. 493-507
Closed Access | Times Cited: 5
Mechanism of Reactive Oxygen Species-Guided Immune Responses in Gouty Arthritis and Potential Therapeutic Targets
Sai Zhang, Daocheng Li, Mingyuan Fan, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 978-978
Open Access | Times Cited: 5
Advances in Personalized Oncology
Hiba Mechahougui, James Gutmans, Gina Colarusso, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2862-2862
Open Access | Times Cited: 5
Advancing Thoracic Surgical Oncology in the Era of Precision Medicine
Giacomo Argento, Erino Angelo Rendina, Giulio Maurizi
Cancers (2025) Vol. 17, Iss. 1, pp. 115-115
Open Access
RUNX1 promotes proliferation of cervical cancer through TGFB2-MAPK pathway
Yongqin Jia, Neng Yang, Shuai Tang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Erdheim–Chester disease: Comprehensive insights from genetic mutations to clinical manifestations and therapeutic advances
Rishabh Chaudhary, Anand Kumar, Alpana Singh, et al.
Disease-a-Month (2025), pp. 101845-101845
Closed Access
Computational Network Analysis of Two Popular Skin Cancers Provides Insights into the Molecular Mechanisms and Reveals Common Therapeutic Targets
Md Abdullah Al Mahmud, Bikash Kumar Paul, Md Rakibul Hasan, et al.
Heliyon (2025) Vol. 11, Iss. 1, pp. e41688-e41688
Open Access
Emerging regulatory mechanisms and functions of biomolecular condensates: implications for therapeutic targets
Soyoung Jeon, Yong‐Duck Chung, Jae‐Sung Lim, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Development of a new flippase-dependent mouse model for red fluorescence-based isolation of KRASG12D oncogene-expressing tumor cells
Dušan Hrčkulák, Jakub Onhajzer, Michaela Krausová, et al.
Transgenic Research (2025) Vol. 34, Iss. 1
Open Access
Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targets
Tomasz Sirek, Katarzyna Król-Jatręga, Przemysław Borawski, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Antitumor Effects of Tryptanthrin on Colorectal Cancer by Regulating the Mitogen-Activated Protein Kinase Signaling Pathway and Targeting Topo I and IDO1
Shing-Hwa Lu, Bao-Long Hou, Ting Wang, et al.
ACS Omega (2025) Vol. 10, Iss. 3, pp. 3206-3221
Open Access
IL-2-loaded liposomes modified with sorafenib derivative exert a synergistic anti-melanoma effect via improving tumor immune microenvironment and enhancing antiangiogenic activity
Xuan Huang, Kudelaidi Kuerban, J P Fan, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101020-101020
Open Access
Page 1 - Next Page

Scroll to top